These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 14510900)

  • 1. Endocrine intervention for transsexuals.
    Levy A; Crown A; Reid R
    Clin Endocrinol (Oxf); 2003 Oct; 59(4):409-18. PubMed ID: 14510900
    [No Abstract]   [Full Text] [Related]  

  • 2. Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people.
    Toorians AW; Thomassen MC; Zweegman S; Magdeleyns EJ; Tans G; Gooren LJ; Rosing J
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5723-9. PubMed ID: 14671159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience.
    Gooren LJ; Giltay EJ; Bunck MC
    J Clin Endocrinol Metab; 2008 Jan; 93(1):19-25. PubMed ID: 17986639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of cross-sex hormonal treatment on plasma asymmetric dimethylarginine (ADMA) in healthy male-to-female and female-to-male transsexuals.
    Bunck MC; Giltay EJ; Diamant M; Gooren LJ; Teerlink T
    Atherosclerosis; 2009 Sep; 206(1):245-50. PubMed ID: 19324362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sex hormone administration changes pain in transsexual women and men.
    Aloisi AM; Bachiocco V; Costantino A; Stefani R; Ceccarelli I; Bertaccini A; Meriggiola MC
    Pain; 2007 Nov; 132 Suppl 1():S60-S67. PubMed ID: 17379410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones.
    Asscheman H; Giltay EJ; Megens JA; de Ronde WP; van Trotsenburg MA; Gooren LJ
    Eur J Endocrinol; 2011 Apr; 164(4):635-42. PubMed ID: 21266549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irreversible physical changes.
    Jacobeit J; Wüsthof A
    Dtsch Arztebl Int; 2009 May; 106(18):318; author reply 318. PubMed ID: 19547648
    [No Abstract]   [Full Text] [Related]  

  • 8. Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review.
    Mancini I; Rotilio A; Coati I; Seracchioli R; Martelli V; Meriggiola MC
    Gynecol Endocrinol; 2018 Jun; 34(6):456-459. PubMed ID: 29105524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals.
    Elbers JM; Asscheman H; Seidell JC; Frölich M; Meinders AE; Gooren LJ
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3267-70. PubMed ID: 9329351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression signatures of breast tissue before and after cross-sex hormone therapy in female-to-male transsexuals.
    Bentz EK; Pils D; Bilban M; Kaufmann U; Hefler LA; Reinthaller A; Singer CF; Huber JC; Horvat R; Tempfer CB
    Fertil Steril; 2010 Dec; 94(7):2688-96. PubMed ID: 20537635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cross-sex hormone treatment on cortical thickness in transsexual individuals.
    Zubiaurre-Elorza L; Junque C; Gómez-Gil E; Guillamon A
    J Sex Med; 2014 May; 11(5):1248-61. PubMed ID: 24617977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones.
    Mueller A; Gooren L
    Eur J Endocrinol; 2008 Sep; 159(3):197-202. PubMed ID: 18567667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcortical gray matter changes in transgender subjects after long-term cross-sex hormone administration.
    Seiger R; Hahn A; Hummer A; Kranz GS; Ganger S; Woletz M; Kraus C; Sladky R; Kautzky A; Kasper S; Windischberger C; Lanzenberger R
    Psychoneuroendocrinology; 2016 Dec; 74():371-379. PubMed ID: 27744092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profound Changes in Sex Hormone Levels during Cross-Sex Hormone Therapy of Transsexuals do not Alter Serum Cholesterol Acceptor Capacity.
    Wultsch A; Kaufmann U; Ott J; Stojakovic T; Scharnagl H; Stangl H; Strobl WM
    J Sex Med; 2015 Jun; 12(6):1436-9. PubMed ID: 25854918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjectures concerning cross-sex hormone treatment of aging transsexual persons.
    Gooren L; Lips P
    J Sex Med; 2014 Aug; 11(8):2012-9. PubMed ID: 24775178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist.
    Dittrich R; Binder H; Cupisti S; Hoffmann I; Beckmann MW; Mueller A
    Exp Clin Endocrinol Diabetes; 2005 Dec; 113(10):586-92. PubMed ID: 16320157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of hypophyseal-testicular function from sex steroid treatment and the pituitary response to castration in male transsexuals.
    Goh HH; Karim SM; Ratnam SS
    Clin Endocrinol (Oxf); 1981 Nov; 15(5):519-23. PubMed ID: 6799232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone treatment of the adult transsexual patient.
    Gooren L
    Horm Res; 2005; 64 Suppl 2():31-6. PubMed ID: 16286768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of sex-steroid administration on the pituitary-thyroid axis in transsexuals.
    Bisschop PH; Toorians AW; Endert E; Wiersinga WM; Gooren LJ; Fliers E
    Eur J Endocrinol; 2006 Jul; 155(1):11-6. PubMed ID: 16793944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The potentials for combined estrogen-androgen therapy in the postmenopause].
    Kolarov G; Nalbanski B; Nikolov A; Orbetsova M; Filipov E
    Akush Ginekol (Sofiia); 1999; 38(2):48-51. PubMed ID: 10730390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.